Literature references that cite this PDB file's
key reference
|
 |
| |
PubMed id
|
|
Reference
|
|
|
|
|
|
K.Hellmuth,
S.Grosskopf,
C.T.Lum,
M.Würtele,
N.Röder,
J.P.von Kries,
M.Rosario,
J.Rademann,
and
W.Birchmeier
(2008).
Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking.
|
| |
Proc Natl Acad Sci U S A, 105,
7275-7280.
|
|
|
|
|
|
|
M.Stuible,
L.Zhao,
I.Aubry,
D.Schmidt-Arras,
F.D.Böhmer,
C.J.Li,
and
M.L.Tremblay
(2007).
Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives.
|
| |
Chembiochem, 8,
179-186.
|
|
|
|
|
|
|
T.Sun,
Q.Wang,
Z.Yu,
Y.Zhang,
Y.Guo,
K.Chen,
X.Shen,
and
H.Jiang
(2007).
Hyrtiosal, a PTP1B inhibitor from the marine sponge Hyrtios erectus, shows extensive cellular effects on PI3K/AKT activation, glucose transport, and TGFbeta/Smad2 signaling.
|
| |
Chembiochem, 8,
187-193.
|
|
|
|
|
|
|
A.G.Evdokimov,
M.Pokross,
R.Walter,
M.Mekel,
B.Cox,
C.Li,
R.Bechard,
F.Genbauffe,
R.Andrews,
C.Diven,
B.Howard,
V.Rastogi,
J.Gray,
M.Maier,
and
K.G.Peters
(2006).
Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.
|
| |
Acta Crystallogr D Biol Crystallogr, 62,
1435-1445.
|
|
|
PDB codes:
|
|
|
|
|
|
|
|
D.Tolkatchev,
R.Shaykhutdinov,
P.Xu,
J.Plamondon,
D.C.Watson,
N.M.Young,
and
F.Ni
(2006).
Three-dimensional structure and ligand interactions of the low molecular weight protein tyrosine phosphatase from Campylobacter jejuni.
|
| |
Protein Sci, 15,
2381-2394.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
A.K.Pedersen,
G.H.Peters G,
K.B.Møller,
L.F.Iversen,
and
J.S.Kastrup
(2004).
Water-molecule network and active-site flexibility of apo protein tyrosine phosphatase 1B.
|
| |
Acta Crystallogr D Biol Crystallogr, 60,
1527-1534.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
C.Wiesmann,
K.J.Barr,
J.Kung,
J.Zhu,
D.A.Erlanson,
W.Shen,
B.J.Fahr,
M.Zhong,
L.Taylor,
M.Randal,
R.S.McDowell,
and
S.K.Hansen
(2004).
Allosteric inhibition of protein tyrosine phosphatase 1B.
|
| |
Nat Struct Mol Biol, 11,
730-737.
|
|
|
PDB codes:
|
|
|
|
|
|
|
|
S.D.Taylor,
and
B.Hill
(2004).
Recent advances in protein tyrosine phosphatase 1B inhibitors.
|
| |
Expert Opin Investig Drugs, 13,
199-214.
|
|
|
|
|
|
|
T.Honma
(2003).
Recent advances in de novo design strategy for practical lead identification.
|
| |
Med Res Rev, 23,
606-632.
|
|
|
|
|
|
|
T.M.Frimurer,
G.H.Peters,
L.F.Iversen,
H.S.Andersen,
N.P.Møller,
and
O.H.Olsen
(2003).
Ligand-induced conformational changes: improved predictions of ligand binding conformations and affinities.
|
| |
Biophys J, 84,
2273-2281.
|
|
|
|
|
|
|
Z.Y.Zhang,
and
S.Y.Lee
(2003).
PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity.
|
| |
Expert Opin Investig Drugs, 12,
223-233.
|
|
|
|
|
|
|
E.Asante-Appiah,
S.Patel,
C.Dufresne,
P.Roy,
Q.Wang,
V.Patel,
R.W.Friesen,
C.Ramachandran,
J.W.Becker,
Y.Leblanc,
B.P.Kennedy,
and
G.Scapin
(2002).
The structure of PTP-1B in complex with a peptide inhibitor reveals an alternative binding mode for bisphosphonates.
|
| |
Biochemistry, 41,
9043-9051.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
H.Fu,
J.Park,
and
D.Pei
(2002).
Peptidyl aldehydes as reversible covalent inhibitors of protein tyrosine phosphatases.
|
| |
Biochemistry, 41,
10700-10709.
|
|
|
|
|
|
|
T.O.Johnson,
J.Ermolieff,
and
M.R.Jirousek
(2002).
Protein tyrosine phosphatase 1B inhibitors for diabetes.
|
| |
Nat Rev Drug Discov, 1,
696-709.
|
|
|
|
|
|
|
Z.Y.Zhang
(2002).
Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.
|
| |
Annu Rev Pharmacol Toxicol, 42,
209-234.
|
|
|
|
|
|
|
G.Scapin,
S.Patel,
V.Patel,
B.Kennedy,
and
E.Asante-Appiah
(2001).
The structure of apo protein-tyrosine phosphatase 1B C215S mutant: more than just an S --> O change.
|
| |
Protein Sci, 10,
1596-1605.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
J.N.Andersen,
O.H.Mortensen,
G.H.Peters,
P.G.Drake,
L.F.Iversen,
O.H.Olsen,
P.G.Jansen,
H.S.Andersen,
N.K.Tonks,
and
N.P.Møller
(2001).
Structural and evolutionary relationships among protein tyrosine phosphatase domains.
|
| |
Mol Cell Biol, 21,
7117-7136.
|
|
|
|
|
|
|
M.Balasubramanyam,
and
V.Mohan
(2001).
Orally active insulin mimics: where do we stand now?
|
| |
J Biosci, 26,
383-390.
|
|
|
|
|
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
296 a.a.
